.
Clinical Pharmacology and Management of Pharmacologically Assisted Care
Study Course Description
Course Description Statuss:Approved
Course Description Version:5.00
Study Course Accepted:26.01.2023 15:57:52
| Study Course Information | |||||||||
| Course Code: | FLK_018 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Clinical Medicine | Target Audience: | Nursing Science | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Līga Henke | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Pharmacology | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, Konsula street 21, 1st floor; Liga[pnkts]Henke rsu[pnkts]lv; Indra[pnkts]Dumbergarsu[pnkts]lv; +371 67613517 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 6 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 12 | ||||
| Classes (count) | 6 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 12 | ||||
| Total Contact Hours | 24 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Anatomy, physiology, biochemistry and histology, pathology, pharmacology. | ||||||||
| Objective: | Students must acquire knowledge of the pharmacological groups of medicines and formulated products, be able to assess the effectiveness and safety of medicines, know what information should be provided about medicines for safe use by the patient. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Histaminergic system, anaphylaxis, antihistamines. Agents used in the pharmacotherapy of allergic conditions | Lectures | 1.00 | auditorium | |||||
| 2 | Analgesics, side effects, interactions thereof | Lectures | 1.00 | auditorium | |||||
| 3 | Antiseptics and antimicrobials. Side effects and interactions thereof | Lectures | 1.00 | auditorium | |||||
| 4 | Pharmacology of agents affecting the central nervous system | Classes | 1.00 | auditorium | |||||
| 5 | Cardiotonics. Agents affecting arterial hypertension. Antiarrhythmics | Lectures | 1.00 | auditorium | |||||
| 6 | Agents affecting the function of the digestive organs | Classes | 1.00 | auditorium | |||||
| 7 | Agents used in the treatment of respiratory diseases | Lectures | 1.00 | auditorium | |||||
| 8 | Specifics of the action of medicines in geriatrics and paediatrics | Lectures | 1.00 | auditorium | |||||
| 9 | Pain and inflammation. Allergies. Antimicrobials | Classes | 1.00 | auditorium | |||||
| 10 | Pharmacology of agents affecting the central nervous system | Classes | 1.00 | auditorium | |||||
| 11 | Hormonal medicines | Classes | 1.00 | auditorium | |||||
| 12 | Pharmacology of effector organs | Classes | 1.00 | auditorium | |||||
| Assessment | |||||||||
| Unaided Work: | Individual work – learning about pharmacology, as well as information on medicines, application and use thereof in the treatment process, analysis of medicines. | ||||||||
| Assessment Criteria: | Regular class tests or colloquia during practical classes. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | After successful fulfilment of the study course requirements, the student will have acquired knowledge, which will allow to describe pharmacotherapeutic groups, as well as to formulate their mechanisms of action, indications and contraindications, as well as side effects. | ||||||||
| Skills: | As a result of completing the study course, students will be able to select the most appropriate medicines in an individualised dosage regimen according to the specific situation to ensure optimal patient treatment and disease prevention. | ||||||||
| Competencies: | As a result of completing the study course, students will be able to: 1. Formulate mechanisms of action of medicines, indications and contraindications, as well as side effects. 2. Independently obtain, select and analyse information about medicines, use thereof in the treatment process. 3. Orient in specific literature. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Indulis Purviņš, Santa Purviņa. Praktiskā farmakoloģija. 4. Izdevums, ZIC, 2011, 896 lpp. (akceptējams izdevums) | ||||||||
| 2 | Basic & Clinical Pharmacology. Bertram G. Katzung. McGraw-Hill Professional, December 13, 2018. | ||||||||
| 3 | Lekciju materiāls RSU E-studijas. | ||||||||
| 4 | Ārvalstu studentiem/For international students: | ||||||||
| 5 | Basic & Clinical Pharmacology. Bertram G. Katzung. McGraw-Hill Professional, December 13, 2018. | ||||||||
| Additional Reading | |||||||||
| 1 | British National Formulary, BNF No. 70, March 2019 | ||||||||
| 2 | Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Ed. Laurence L. Brunton, et al. New York, NY: McGraw-Hill, 2022 | ||||||||
| 3 | Pharmacotherapy Handbook. Barbara G Wells. McGraw-Hill Medical, October 10, 2021, 1164 pages | ISBN-10: 0071748342 | ISBN-13: 978-0071748346 | ||||||||
| 4 | Autoru kolektīvs profesora Aivara Lejnieka redakcijā. Klīniskā medicīna, 2010-2012 | ||||||||
| 5 | Ārvalstu studentiem/For international students: | ||||||||
| 6 | British National Formulary, BNF No. 70, March 2019 | ||||||||
| 7 | Pharmacotherapy Handbook. Barbara G Wells. McGraw-Hill Medical, October 10, 2021, 1164 pages | ISBN-10: 0071748342 | ISBN-13: 978-0071748346 | ||||||||
| Other Information Sources | |||||||||
| 1 | https://www.zva.gov.lv/ | ||||||||
| 2 | www.vm.gov.lv | ||||||||
| 3 | www.EMCDDA.europa.eu/ | ||||||||
| 4 | Ārvalstu studentiem/For international students: | ||||||||
| 5 | www.EMCDDA.europa.eu/ | ||||||||
